Xiangmei May Wu1, Rupa Basu2, Brian Malig2, Rachel Broadwin2, Keita Ebisu2, Ellen B Gold3, Lihong Qi3, Carol Derby4, Rochelle S Green2. 1. Air and Climate Epidemiology Section, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, CA, USA. Electronic address: xiangmei.wu@oehha.ca.gov. 2. Air and Climate Epidemiology Section, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, CA, USA. 3. Department of Public Health Sciences, University of California Davis, School of Medicine, Davis, CA, USA. 4. Albert Einstein College of Medicine, Bronx, NY, USA.
Abstract
BACKGROUND: Exposures to ambient gaseous pollutants have been linked to cardiovascular diseases (CVDs), but the biological mechanisms remain uncertain. OBJECTIVES: This study examined the changes in CVD marker levels resulting from elevated exposure to ambient gaseous pollutants in midlife women. METHODS: Annual repeated measurements of several inflammatory, hemostatic and lipid makers were obtained from 2306 midlife women enrolled in the longitudinal Study of Women's Health Across the Nation (SWAN) between 1999 and 2004. Ambient carbon monoxide (CO), nitrogen dioxide (NO2), and sulfur dioxide (SO2) data were assigned to each woman based on proximity of the monitoring station to her residential address. Short- and long-term exposures were calculated, and their associations with markers were examined using linear mixed-effects regression models, adjusted for demographic, health and other factors. RESULTS: Short-term CO exposure was associated with increased fibrinogen, i.e., every interquartile increase of average prior one-week exposure to CO was associated with 1.3% (95% CI: 0.6%, 2.0%) increase in fibrinogen. Long-term exposures to NO2 and SO2 were associated with reduced high-density lipoproteins and apolipoprotein A1, e.g., 4.0% (1.7%, 6.3%) and 4.7% (2.8%, 6.6%) decrease per interquartile increment in prior one-year average NO2 concentration, respectively. Fine particle (PM2.5) exposure confounded associations between CO/NO2 and inflammatory/hemostatic markers, while associations with lipoproteins were generally robust to PM2.5 adjustment. CONCLUSIONS: Exposures to these gas pollutants at current ambient levels may increase thrombotic potential and disrupt cholesterol metabolism, contributing to greater risk of CVDs in midlife women. Caution should be exercised in evaluating the confounding by PM2.5 exposure.
BACKGROUND: Exposures to ambient gaseous pollutants have been linked to cardiovascular diseases (CVDs), but the biological mechanisms remain uncertain. OBJECTIVES: This study examined the changes in CVD marker levels resulting from elevated exposure to ambient gaseous pollutants in midlife women. METHODS: Annual repeated measurements of several inflammatory, hemostatic and lipid makers were obtained from 2306 midlife women enrolled in the longitudinal Study of Women's Health Across the Nation (SWAN) between 1999 and 2004. Ambient carbon monoxide (CO), nitrogen dioxide (NO2), and sulfur dioxide (SO2) data were assigned to each woman based on proximity of the monitoring station to her residential address. Short- and long-term exposures were calculated, and their associations with markers were examined using linear mixed-effects regression models, adjusted for demographic, health and other factors. RESULTS: Short-term CO exposure was associated with increased fibrinogen, i.e., every interquartile increase of average prior one-week exposure to CO was associated with 1.3% (95% CI: 0.6%, 2.0%) increase in fibrinogen. Long-term exposures to NO2 and SO2 were associated with reduced high-density lipoproteins and apolipoprotein A1, e.g., 4.0% (1.7%, 6.3%) and 4.7% (2.8%, 6.6%) decrease per interquartile increment in prior one-year average NO2 concentration, respectively. Fine particle (PM2.5) exposure confounded associations between CO/NO2 and inflammatory/hemostatic markers, while associations with lipoproteins were generally robust to PM2.5 adjustment. CONCLUSIONS: Exposures to these gas pollutants at current ambient levels may increase thrombotic potential and disrupt cholesterol metabolism, contributing to greater risk of CVDs in midlife women. Caution should be exercised in evaluating the confounding by PM2.5 exposure.
Authors: Meghan M Channell; Michael L Paffett; Robert B Devlin; Michael C Madden; Matthew J Campen Journal: Toxicol Sci Date: 2012-02-13 Impact factor: 4.849
Authors: Carol A Derby; Sybil L Crawford; Richard C Pasternak; Maryfran Sowers; Barbara Sternfeld; Karen A Matthews Journal: Am J Epidemiol Date: 2009-04-08 Impact factor: 4.897
Authors: Jeremy P Langrish; Magnus Lundbäck; Stefan Barath; Stefan Söderberg; Nicholas L Mills; David E Newby; Thomas Sandström; Anders Blomberg Journal: Inhal Toxicol Date: 2010-02 Impact factor: 2.724
Authors: Kazuhiko Ito; Robert Mathes; Zev Ross; Arthur Nádas; George Thurston; Thomas Matte Journal: Environ Health Perspect Date: 2011-04 Impact factor: 9.031
Authors: Ralph J Delfino; Norbert Staimer; Thomas Tjoa; Daniel L Gillen; Andrea Polidori; Mohammad Arhami; Micheal T Kleinman; Nosratola D Vaziri; John Longhurst; Constantinos Sioutas Journal: Environ Health Perspect Date: 2009-04-29 Impact factor: 9.031
Authors: Regina Rückerl; Sonja Greven; Petter Ljungman; Pasi Aalto; Charalambos Antoniades; Tom Bellander; Niklas Berglind; Christina Chrysohoou; Francesco Forastiere; Bénédicte Jacquemin; Stephanie von Klot; Wolfgang Koenig; Helmut Küchenhoff; Timo Lanki; Juha Pekkanen; Carlo A Perucci; Alexandra Schneider; Jordi Sunyer; Annette Peters Journal: Environ Health Perspect Date: 2007-07 Impact factor: 9.031
Authors: Emilie Davis; Brian Malig; Rachel Broadwin; Keita Ebisu; Rupa Basu; Ellen B Gold; Lihong Qi; Carol A Derby; Sung Kyun Park; Xiangmei May Wu Journal: Environ Health Date: 2020-11-05 Impact factor: 5.984